ReviewDiabetes, obesity & metabolismPublished
Assessing the benefit-risk profile of newer glucose-lowering drugs: A systematic review and network meta-analysis of randomized outcome trials
Regional connection
Verified Author affiliations on the Europe PMC record name Penn Medicine, Perelman School of Medicine, University of Pennsylvania. Affiliation source
- County
- Philadelphia County
Publication record
- Type
- Review
- Venue
- Diabetes, obesity & metabolism
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Blood Glucose; Hypoglycemic Agents; Risk Assessment; Randomized Controlled Trials as Topic; Dipeptidyl-Peptidase IV Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Glucagon-Like Peptide-1 Receptor Agonists; Type 2 diabetes; Sglt2 Inhibitor
- PubMed ID
- 39723481
- PubMed Central ID
- PMC12135018
- Open access
- Yes, accepted manuscript
- Added to directory
- Source checked